Pricing Log in Create free account
Saturday 17 October 2026 Export CAH’s income statement to Excel — free account

Cardinal Health, Inc.

CAH Healthcare Medical Distribution

Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025. In the quarter to June 2026, revenue grew 5.84%, EPS grew 68.3%, free cash flow grew 10.9% and total debt rose 4.21%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

254.06 0.35 +0.14%
Market cap
$58.8B
P/E
35.0×
Fwd P/E
23.3×
Dividend yield
0.81%
F-score
7/9
Altman Z
5.09
Beneish M
−2.74
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Cardinal Health, Inc. (CAH) SEC filings, changes and red flags

Red flags

  • Impairment

    Cardinal Health, Inc. recorded a goodwill impairment of $184.0 million in fiscal 2026

    10-K filed · The filing · sec.gov

  • Officer departure

    Cardinal Health, Inc. reported the departure of an officer or director

    8-K filed · The filing · sec.gov

Filings

Form Period Filed What it reports Flags
8-K Oct 1, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-K Jun 30, 2026 1: no comparison — the Item was not found
1A: no comparison — the Item was not found
7: no comparison — the Item was not found 		Impairment
8-K Aug 11, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Aug 7, 2026 1.01 Entry into a material definitive agreement; 1.02 Termination of a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K Aug 4, 2026 5.02 Departure or appointment of directors or officers Officer departure
10-Q Mar 31, 2026 P1I2: no comparison — the Item was not found
P2I1A: no comparison — the Item was not found
8-K Apr 30, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Mar 17, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Mar 2, 2026 5.02 Departure or appointment of directors or officers
10-Q Dec 31, 2025
8-K Feb 5, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jan 13, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Nov 5, 2025 5.07 Submission of matters to a vote of security holders
10-Q Sep 30, 2025
8-K Oct 30, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Oct 7, 2025 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits
8-K Sep 30, 2025 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits
8-K Aug 27, 2025 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
10-K Jun 30, 2025
10-Q Mar 31, 2025

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.